MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 52 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,560 | -66.7% | 12,000 | -7.7% | 0.00% | – |
| Q2 2023 | $4,680 | -29.9% | 13,000 | -8.5% | 0.00% | – |
| Q1 2023 | $6,674 | -60.7% | 14,200 | -54.5% | 0.00% | – |
| Q4 2022 | $17,000 | -19.0% | 31,200 | 0.0% | 0.00% | – |
| Q3 2022 | $21,000 | -12.5% | 31,200 | 0.0% | 0.00% | – |
| Q2 2022 | $24,000 | -4.0% | 31,200 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | -19.4% | 31,200 | 0.0% | 0.00% | – |
| Q4 2021 | $31,000 | -8.8% | 31,200 | +19.1% | 0.00% | – |
| Q3 2021 | $34,000 | +100.0% | 26,200 | +18.0% | 0.00% | – |
| Q2 2021 | $17,000 | -26.1% | 22,200 | 0.0% | 0.00% | – |
| Q1 2021 | $23,000 | -14.8% | 22,200 | +11.0% | 0.00% | – |
| Q4 2020 | $27,000 | +80.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | +200.0% | 20,000 | +233.3% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
| Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
| IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
| Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
| Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
| BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
| Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |